<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Pharmacology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4F3E2189-C0E5-406E-9F4F-6D3998C8E0D0"><gtr:id>4F3E2189-C0E5-406E-9F4F-6D3998C8E0D0</gtr:id><gtr:firstName>Grant</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Churchill</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD012694%2F1"><gtr:id>4A529669-70EA-4118-B0AC-3AD87DFBA6B2</gtr:id><gtr:title>Synthesis and biological testing of cell-permeant NAADP</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D012694/1</gtr:grantReference><gtr:abstractText>Cells communicate with other cells and internally via chemical messengers. These messenger are molecules and exhibit features that make them uniquely recognizable to specialised receptors, or biological message centres. Messengers are made inside the cell membrane in response to outside stimuli, but cannot cross to or from the outside. This is because cells are enveloped by a membrane which keeps the contents in and potential contaminants outside. We are interested in a messenger molecule that increases calcium levels inside cells, called NAADP. Changes in calcium levels is what drives your heart to contract, your arm muscle to contract to raise a cup to your mouth and even the cells in your brain to talk to each other. Nobody is yet sure NAADP is working, so we want to get it into cells and find out. This messenger molecule does not naturally cross the cell membrane, so current state of the art techniques involve destroying the membrane then rebuilding it. This is difficult and requires specialised skills. We propose to try a different, more subtle approach by masking the molecules appearance, so that it can slip through the membrane. Once inside, the molecule sheds its mask, regains its appearance and provides its message. Getting NAADP across the cell membrane by stealth will provide us with new information about how this messenger works in different cells. Successful development of this new method will allow many more scientists to study this fascinating molecule.</gtr:abstractText><gtr:technicalSummary>Inside cells calcium functions as a messenger and drives many processes such as fertilization, muscle contraction, secretion and even regulated cell death. The molecule NAADP (nicotinic acid adenine dinucleotide phosphate) releases calcium from intracellular stores and may also stimulate influx. Although NAADP is known to releases calcium in several cell types, including many mammalian cells, the precise physiological role of NAADP is ill defined in all but the pancreatic acinar cells. A large impediment to research in this area is that NAADP has three phosphates and a carboxylic acid group and thus possesses a net negative charge. Being relatively large and highly charged it is does not cross membranes and has to be introduced by microinjection or other techniques that breech the plasma membrane. Cell permeant versions of NAADP would greatly facilitate research into NAADP in all mammalian cell types in which it has been implicated to have a role (based on calcium release). Moreover, cell-permeant caged NAADP would enable many elegant experiments that would reveal much about the physiology of NAADP. To this end, we are particularly excited about a role for NAADP in serotonin (5-hydroxytryptamine) signalling in the brain. We propose to make cell-permeant and caged versions of NAADP, fully characterize them in terms of uptake and metabolism, and then use them to further define the role of NAADP in serotonin signalling.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>213015</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Academically, we provided two novel chemical tools: a cell-permeant NAADP as an agonist and Ned-19 as an antagonist. Prior to this, NAADP itself had to be used with very demanding and rare techniques. These chemical tools have opened up the field of NAADP signalling to the wider calcium community and biological community in general. They have now been used in hundreds of labs and appeared in almost 100 publications, with more to come.



Economically, we patented the compound Ned-19, but it was dropped by our tech transfer division. Subsequently, 8 companies worldwide are synthesizing and selling Ned-19. The tech transfer division of our university is selling our 'excess' NAADP-AM, but demand is outstripping supply and we are in discussions with a chemical supplier to step in.</gtr:description><gtr:id>E167B2C6-0926-4072-8132-7A7C48E19D1B</gtr:id><gtr:impactTypes><gtr:impactType>Cultural,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>m-3269646347.7515116de27c57e</gtr:outcomeId><gtr:sector>Chemicals</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A940780A-7D72-4C18-B70A-F520ACA91572</gtr:id><gtr:title>NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d503c5d62315dc31195b2a90e7c9a193"><gtr:id>d503c5d62315dc31195b2a90e7c9a193</gtr:id><gtr:otherNames>Thai TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>545bc27ede8458.16372379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADA3058-BFE5-4D12-9E50-E080E313E74E</gtr:id><gtr:title>Preparation and use of sea urchin egg homogenates for studying NAADP-mediated Ca&amp;sup2;? release.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56665c5faea84d8775b650a48f358cd5"><gtr:id>56665c5faea84d8775b650a48f358cd5</gtr:id><gtr:otherNames>Galione A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-6095</gtr:issn><gtr:outcomeId>545bc282bdaf99.11146233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90FD27BC-DC7B-4B43-BC8A-8D8BADDF0AE9</gtr:id><gtr:title>Refinement of a radioreceptor binding assay for nicotinic acid adenine dinucleotide phosphate.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8469904b473a368dc2df6bcd122fe42"><gtr:id>a8469904b473a368dc2df6bcd122fe42</gtr:id><gtr:otherNames>Lewis AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>545bc27d90cd27.71305804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9E9D5FE-F6F7-45E8-9538-42FBA4D5C61A</gtr:id><gtr:title>Nicotinic acid adenine dinucleotide phosphate regulates skeletal muscle differentiation via action at two-pore channels.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab546a1fd5f9b29527b13867df42afb5"><gtr:id>ab546a1fd5f9b29527b13867df42afb5</gtr:id><gtr:otherNames>Aley PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545bc2806b6912.88213919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>707E1A53-2198-4D20-BBC2-7BFE8CB9082C</gtr:id><gtr:title>Acidic NAADP-sensitive calcium stores in the endothelium: agonist-specific recruitment and role in regulating blood pressure.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f2daa0d154a79a5d493656035a09c9a"><gtr:id>6f2daa0d154a79a5d493656035a09c9a</gtr:id><gtr:otherNames>Brailoiu GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545bc28047ec56.21574230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>960C47FB-9341-4EF6-A4DA-EA8B5C5E5DED</gtr:id><gtr:title>Sperm express a Ca2+-regulated NAADP synthase.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ddd8b9c9de7c6ae9a3adccbe559a96a"><gtr:id>1ddd8b9c9de7c6ae9a3adccbe559a96a</gtr:id><gtr:otherNames>Vasudevan SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>545bc27e0e7952.82247713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1E3B862-1A08-4BD0-8852-771D9C1CA31F</gtr:id><gtr:title>Synthesis of caged NAADP.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56665c5faea84d8775b650a48f358cd5"><gtr:id>56665c5faea84d8775b650a48f358cd5</gtr:id><gtr:otherNames>Galione A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-6095</gtr:issn><gtr:outcomeId>545bbfaf6c79b5.64201003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38FDCBF2-7D11-4272-AA12-1D03E336E409</gtr:id><gtr:title>Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70d95cadb3b96633358ddc403269b59b"><gtr:id>70d95cadb3b96633358ddc403269b59b</gtr:id><gtr:otherNames>Lloyd-Evans E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>545bc27e70e6a5.06111574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C181667F-EB82-4553-B228-91C59EB51222</gtr:id><gtr:title>Synthesis of [&amp;sup3;&amp;sup2;P]NAADP for the radioreceptor binding assay.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56665c5faea84d8775b650a48f358cd5"><gtr:id>56665c5faea84d8775b650a48f358cd5</gtr:id><gtr:otherNames>Galione A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-6095</gtr:issn><gtr:outcomeId>545bc282e36040.21423862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDD40CC7-1360-4905-A7DC-C64DA02590A6</gtr:id><gtr:title>A safe lithium mimetic for bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ced39d1f99179e5ffe5edc968b042a67"><gtr:id>ced39d1f99179e5ffe5edc968b042a67</gtr:id><gtr:otherNames>Singh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_5435b095b09db7bb6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8A24944-4736-44E9-98B9-60D84BA3C321</gtr:id><gtr:title>Cell-permeant NAADP: a novel chemical tool enabling the study of Ca2+ signalling in intact cells.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/459f96f62e164290498a60e8aacddc46"><gtr:id>459f96f62e164290498a60e8aacddc46</gtr:id><gtr:otherNames>Parkesh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>545bc27db8fa59.72415070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B029EDD-3126-489F-92C9-76D0D20B5061</gtr:id><gtr:title>?-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8469904b473a368dc2df6bcd122fe42"><gtr:id>a8469904b473a368dc2df6bcd122fe42</gtr:id><gtr:otherNames>Lewis AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>pm_15708_28_22995315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F07DF8D-B84E-4BEA-90A4-375DF023E214</gtr:id><gtr:title>NAADP controls cross-talk between distinct Ca2+ stores in the heart.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d282f160c2edc5779e3fded27d85feea"><gtr:id>d282f160c2edc5779e3fded27d85feea</gtr:id><gtr:otherNames>Macgregor A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545bc27d6bb510.27653501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88A0BCDB-8F13-4C76-AAA1-01E2AB4386DA</gtr:id><gtr:title>Chemo-enzymatic synthesis and biological evaluation of photolabile nicotinic acid adenine dinuclotide phosphate (NAADP+).</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/459f96f62e164290498a60e8aacddc46"><gtr:id>459f96f62e164290498a60e8aacddc46</gtr:id><gtr:otherNames>Parkesh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>545bc27d20ccc4.63318867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F2D796-1D31-4881-A871-1FBD6ABC5D15</gtr:id><gtr:title>Cellular confocal fluorescence studies and cytotoxic activity of new Zn(II) bis(thiosemicarbazonato) complexes.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6412ed59d72e6c2104f0a8cb06ffb0"><gtr:id>7b6412ed59d72e6c2104f0a8cb06ffb0</gtr:id><gtr:otherNames>Pascu SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>545bc27e4d1e11.05532865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BA712BE-8107-4068-8863-38349DA905FF</gtr:id><gtr:title>Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.</gtr:title><gtr:parentPublicationTitle>Inorganic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d825abb091d18f2c534d2db713d48df"><gtr:id>5d825abb091d18f2c534d2db713d48df</gtr:id><gtr:otherNames>Holland JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-1669</gtr:issn><gtr:outcomeId>545bc27d438604.70151923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE3E74FE-AF3C-4697-B8D6-250733EAD9AF</gtr:id><gtr:title>Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d54867df83bb1d003110c7f9a8acc4d4"><gtr:id>d54867df83bb1d003110c7f9a8acc4d4</gtr:id><gtr:otherNames>Dowden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>545bc27cefa7f5.66722462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>118AA622-2706-499E-B424-814077ACE831</gtr:id><gtr:title>Synthesis of NAADP-AM as a membrane-permeant NAADP analog.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56665c5faea84d8775b650a48f358cd5"><gtr:id>56665c5faea84d8775b650a48f358cd5</gtr:id><gtr:otherNames>Galione A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-6095</gtr:issn><gtr:outcomeId>545bc283157f44.05965166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C010789-10A5-44EA-B2E4-356F193DBC68</gtr:id><gtr:title>A functional role for nicotinic acid adenine dinucleotide phosphate in oxytocin-mediated contraction of uterine smooth muscle from rat.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab546a1fd5f9b29527b13867df42afb5"><gtr:id>ab546a1fd5f9b29527b13867df42afb5</gtr:id><gtr:otherNames>Aley PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>545bc27faaf4c6.39661848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7926C82-5C15-4449-BDC1-D6CA28AD042A</gtr:id><gtr:title>Designing Zn(II) and Cu(II) derivatives as probes for in vitro fluorescence imaging.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6412ed59d72e6c2104f0a8cb06ffb0"><gtr:id>7b6412ed59d72e6c2104f0a8cb06ffb0</gtr:id><gtr:otherNames>Pascu SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>545bc27ddd27e8.96745227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F19770F-9F00-4314-8D18-3D9DECAF63D3</gtr:id><gtr:title>NAADP-mediated channel 'chatter' in neurons of the rat medulla oblongata.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f2daa0d154a79a5d493656035a09c9a"><gtr:id>6f2daa0d154a79a5d493656035a09c9a</gtr:id><gtr:otherNames>Brailoiu GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>545bc27e96a578.79945176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>522DD577-17F3-4A1D-AD46-622E81BA2D6B</gtr:id><gtr:title>Deviant nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca2+ signaling upon lysosome proliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020dfc2ffe431fc00e7520a6cdecedc0"><gtr:id>020dfc2ffe431fc00e7520a6cdecedc0</gtr:id><gtr:otherNames>Dickinson GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545bc27f86c594.05654477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC5D1CF2-0D70-449E-8072-DD05435AAD1F</gtr:id><gtr:title>Scaffold hopping with virtual screening from IP3 to a drug-like partial agonist of the inositol trisphosphate receptor.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ddd8b9c9de7c6ae9a3adccbe559a96a"><gtr:id>1ddd8b9c9de7c6ae9a3adccbe559a96a</gtr:id><gtr:otherNames>Vasudevan SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>5675dcd2e0697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D7C168B-C86A-45B4-8058-DE9BB18B0046</gtr:id><gtr:title>Identification of a chemical probe for NAADP by virtual screening.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a52634b557d2fe79edc1f080db1f59"><gtr:id>b9a52634b557d2fe79edc1f080db1f59</gtr:id><gtr:otherNames>Naylor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>545bc27eb92d81.26946327</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D012694/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>